5-amino-1mq nnmt inhibitor study Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target 5-Amino-1MQ NNMT Inhibitor for Research

Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant

Shorten the cycle if: results have plateaued for 2+ weeks despite dose optimization, you are experiencing fatigue or other signs of potential receptor desensitization, or your goals have been achieved before the planned cycle end

It is a small synthetic molecule that blocks an enzyme called NNMT (nicotinamide N-methyltransferase)

The peptide belongs to a class of compounds known as growth hormone fragments or lipolytic peptides